Regulating the leukaemia stem cell

被引:13
作者
Cleary, Michael L. [1 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
关键词
acute myeloid leukaemia; cancer stem cells; embryonic stem cells; expression; leukaemic stem cells; xenotransplantation; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION SIGNATURE; MLL; IDENTIFICATION; TRANSFORMATION; HETEROGENEITY; MLL-AF9; AML;
D O I
10.1016/j.beha.2009.08.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Leukaemia stem cells (LSCs) are responsible for sustaining and propagating malignant disease, and, as such, are promising targets for therapy. Studies of human LSCs have served an important role in defining the major tenets of the cancer stem cell model, which centre on the frequencies of cancer stein cells, their potential hierarchical organisation and their degree of maturation. LSCs in acute myeloid leukaemia (AML) have recently been studied using mouse syngeneic models of leukaemia induced by MLL oncogenes. These studies have revealed that LSCs are more analogous to progenitor cells and employ embryonic stem cell-like genetic programmes for their maintenance, prompting a refinement of the original cancer stem cell model with important implications for design of therapies to selectively target LSCs. (c) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:483 / 487
页数:5
相关论文
共 16 条
[1]
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors [J].
Ben-Porath, Ittai ;
Thomson, Matthew W. ;
Carey, Vincent J. ;
Ge, Ruping ;
Bell, George W. ;
Regev, Aviv ;
Weinberg, Robert A. .
NATURE GENETICS, 2008, 40 (05) :499-507
[2]
Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD 117) [J].
Blair, A ;
Sutherland, HJ .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (06) :660-671
[3]
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].
Bonnet, D ;
Dick, JE .
NATURE MEDICINE, 1997, 3 (07) :730-737
[4]
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors [J].
Cozzio, A ;
Passegué, E ;
Ayton, PM ;
Karsunky, H ;
Cleary, ML ;
Weissman, IL .
GENES & DEVELOPMENT, 2003, 17 (24) :3029-3035
[5]
MLL rearrangements in haematological malignancies: Lessons from clinical and biological studies [J].
DiMartino, JF ;
Cleary, ML .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) :614-626
[6]
MLL: a histone methyltransferase disrupted in leukemia [J].
Hess, JL .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (10) :500-507
[7]
Tumor growth need not be driven by rare cancer stem cells [J].
Kelly, Priscilla N. ;
Dakic, Aleksandar ;
Adams, Jerry M. ;
Nutt, Stephen L. ;
Strasser, Andreas .
SCIENCE, 2007, 317 (5836) :337-337
[8]
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9 [J].
Krivtsov, Andrei V. ;
Twomey, David ;
Feng, Zhaohui ;
Stubbs, Matthew C. ;
Wang, Yingzi ;
Faber, Joerg ;
Levine, Jason E. ;
Wang, Jing ;
Hahn, William C. ;
Gilliland, D. Gary ;
Golub, Todd R. ;
Armstrong, Scott A. .
NATURE, 2006, 442 (7104) :818-822
[9]
Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL [J].
Lavau, C ;
Szilvassy, SJ ;
Slany, R ;
Cleary, ML .
EMBO JOURNAL, 1997, 16 (14) :4226-4237
[10]
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML [J].
Pearce, DJ ;
Taussig, D ;
Zilbara, K ;
Smith, LL ;
Ridler, CM ;
Preudhomme, C ;
Young, BD ;
Rohatiner, AZ ;
Lister, TA ;
Bonnet, D .
BLOOD, 2006, 107 (03) :1166-1173